Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jami Mandelin

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
American Journal of Human Genetics|June 25, 2002
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotypeJuha Paloneva, Tuula Manninen, Grant Christman, et al.
Cancer|February 19, 2009
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontinJami Mandelin, Emme C K Lin, Dana D Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
Nature Nanotechnology|March 16, 2010
Three-dimensional tissue culture based on magnetic cell levitationGlauco R Souza, Jennifer R Molina, Robert M Raphael, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switchDiana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical TrialReetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Cell Reports. Medicine|December 6, 2023
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trialJenna H Rannikko, Loic Verlingue, Maria de Miguel, et al.
Plos One|April 9, 2013
Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthmaNathalie Acevedo, Annika Sääf, Cilla Söderhäll, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Human Genetics|June 25, 2002
Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotypeJuha Paloneva, Tuula Manninen, Grant Christman, et al.
Cancer|February 19, 2009
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontinJami Mandelin, Emme C K Lin, Dana D Hu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
Nature Nanotechnology|March 16, 2010
Three-dimensional tissue culture based on magnetic cell levitationGlauco R Souza, Jennifer R Molina, Robert M Raphael, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switchDiana N Nunes, Emmanuel Dias-Neto, Marina Cardó-Vila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical TrialReetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Cell Reports. Medicine|December 6, 2023
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trialJenna H Rannikko, Loic Verlingue, Maria de Miguel, et al.
Plos One|April 9, 2013
Interaction between retinoid acid receptor-related orphan receptor alpha (RORA) and neuropeptide S receptor 1 (NPSR1) in asthmaNathalie Acevedo, Annika Sääf, Cilla Söderhäll, et al.
Pageof 3